In addition, LGALS1 is identified as driver genes in the CML cancer subtype 1 and previous works also find that LGALS1 can be selected as a critical biomarker of CML [46]. This evidence concerns the gene LGALS1 and chronic myelogenous leukemia, BCR-ABL1 positive.